Why Children’s Place Shares Are Slumping Today
Children's Place faces a slump as Q4 net sales expectations fall below prior guidance, triggering a significant drop in share value.
What’s Going With Medical Professionals-Networking Service Doximity Stock Today?
Doximity exceeds Q3 2024 expectations with $135.3 million revenue, up 17% YoY. CEO Jeff Tangney highlights double-digit growth, beating adjusted EPS and raising FY2024 outlook.
Pipeline Powerhouse Plains All American’s Q4 Earnings Leap Forward, Eyes Hefty Cash Flow in 2024
Plains All American Pipeline LP (PAA) reports strong Q4 2023 results, beating EPS consensus. Expects continued growth and increased returns in 2024.
Protolabs Sees Softer Start To 2024 Despite Hitting $500M Milestone Revenue In 2023: Details
Proto Labs, Inc. reported strong Q4 results, with revenue up 8.2% YoY and exceeding expectations. The company expects softer start to 2024, due to December 2023 and early January 2024 order levels being lower than historical periods.
Why Newell Brands Shares Are Slumping Today
Newell Brands shares plummet as fourth-quarter revenues drop 9.1%. Normalized EPS of $0.22 topped the consensus of $0.17.
Why Is Automotive Supplier Magna Stock Falling Today?
Magna's Q4 2023 performance with $10.45 billion in sales, a 9% YoY increase. Dive into details on dividends, adjusted EBIT, and guidance for fiscal years 2024 and 2026.
Why HR & Payroll Provider Paylocity Shares Are Diving Today
Paylocity impresses with a 20% year-over-year surge in Q2 FY24 revenue, reaching $326.4 million and surpassing analyst forecasts. Paylocity's innovative AI-driven initiatives propel growth, with Co-CEO Steve Beauchamp highlighting a 16% increase in recurring revenue.
Telus Corp’s Q4 Revenue Growth Driven by Digital Health and Tech Solutions – What’s Behind the Surge?
Telus Corp reports 2.8% growth in Q4 operating revenues, beating adjusted EPS consensus. TELUS Health and TTech see growth, 7.6% increase in telecom connections.
DNA Sequencing Kit Provider Illumina’s Q4 Earnings Edge Above Street Estimates, Works To Resolve GRAIL Quickly
Illumina exceeds Q4 2023 expectations with $1.12 billion sales, up 4% YoY. CEO Jacob Thaysen anticipates growth and outlines strategic priorities for 2024.
Continuous Glucose Monitor Maker Dexcom’s Q4 Profit Triples On Volume Growth And New Customer Additions
Dexcom's Q4 2023 performance, reporting $1.03 billion sales, $256.3 million profits, and beating estimates. Dexcom projects $4.15-$4.35 billion in 2024 revenues. William Blair affirms Outperform rating.